International Symposium on Evidence-based Cochrane Reviews in Haematology: 10th anniversary of the Cochrane Haematological Malignancies Group
CHMG-Symposium: Programme
Friday, July 8th, 2011
9.00 am to 4 p.m
University Hospital of Cologne, Germany
Invited speakers:
Dr. Gerd Antes, German Cochrane Centre, Freiburg (DE)
Prof. Peter Borchmann, University Hospital of Cologne, Clinic I for Internal Medicine, Cologne (DE)
Prof. Ben Djulbegovic, Lee Moffitt Cancer Centre and Research Institute, University of South Florida, Tampa, Tampa (USA)
Prof. Andreas Engert, Clinic I for Internal Medicine, Cologne (DE)
Dr. Markus Follmann, German Cancer Society, Berlin (DE)
Céline Fournier, WA Centre for Cancer and Palliative Care, Curtin University, Perth (AU)
Prof. Michael Hallek, Clinic I for Internal Medicine, University Hospital of Cologne (DE)
Dr. Rainer Hess, Federal Joint Committee (G-BA), Berlin (DE)
Prof. Axel Heyll, Medical Review Board of Statutory Health Insurance Funds North-Rhine, Düsseldorf (DE)
Dr. Martin Hutchings, Department of Oncology, Copenhagen University Hospital (DK)
Prof. Tom Jefferson, Cochrane Acute Respiratory Infections Group, Rome (IT)
Prof. Ina Kopp, AWMF, Institute for the Management of Medical Knowledge, Marburg/Lahn (DE)
Prof. Dr. Thomas Krieg, Medical Faculty of the University of Cologne (DE)
Toby Lasserson, Msc, Cochrane Editorial Unit, London (GB)
Dr. Monika Lelgemann, Medical Service of the Central Federal Association of Health Insurance, Essen (DE)
Prof. Pia Raanani, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva (IL)
Dr. Sue Richards, Clinical Trials Services Unit, Oxford University (GB)
PD Dr. Stephan Schmitz, Practicing haematologists and oncologists in Germany (BNHO), Cologne (DE)
Dr. Nicole Skoetz, Clinic I for Internal Medicine, University Hospital of Cologne (DE)
Prof. Lena Specht, Department of Oncology, Copenhagen University Hospital (DK)
Dr. Christiane Steinmüller, Project Management Agency in the DLR (PT-DLR) on behalf of the Federal Ministry of Education and Research (BMBF), Bonn (DE)
Dr. Siegfried Throm, vfa, Research-based Pharmaceutical Companies, Berlin (DE)
Dr. Sven Trelle, Institute of Social and Preventive Medicine, University of Bern (CH)
Prof. Keith Wheatley, Cancer Research UK Clinical Trials Unit, University of Birmingham (GB)
Prof. Jürgen Windeler, Institute for Quality and Efficiency in Health Care (IQWiG), Cologne (DE)
For further information please contact Ms Schmidtke at Bettina.Schmidtke@uk-koeln.de
Andreas Engert, MD, Co-ordinating Editor CHMG and the Team of the Editorial Base